logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (v) Percentage distribution of new inpatient clients by age at first use for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives8.421.815.712.811.37.66.715.729.934458
Volatile substances54.
Cannabis 30.346.
Other substances 12.53513.811.357.53.811.325.88070


 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2007 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008